Crunchbase News
APRIL 2, 2024
Wonder ’s big $700 million raise may have captured most people’s attention last month, but the story when it came for large deals was really biotech. Mirador Therapeutics , $400M, biotech: It was a huge month for big biotech raises and this was the biggest. Check out the biggest rounds of last month here.
Crunchbase News
MAY 2, 2024
April also saw a half-dozen rounds of a quarter-billion dollars or more, including a $1 billion round for an AI-enhanced biotech. Xaira Therapeutics , $1B, biotech: The biggest round in April was really big. A startup needed to raise $200 million or more to break into this list for the April edition. Let’s take a look.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Crunchbase News
APRIL 19, 2024
Metsera , $290M, biotech: This week was a slower week than normal for biotech — as it was for most sectors — but that didn’t stop New York-based Metsera. Late last month, optical interconnectivity startup Celestial AI raised a massive $175 million Series C led by Thomas Tull ’s US Innovative Technology Fund.
Crunchbase News
MARCH 29, 2024
While there were no huge rounds like last week, money was again spread around from AI to biotech to marketing and more. Celestial AI , $175M, semiconductors: Optical interconnectivity startup Celestial AI raised a massive $175 million Series C led by Thomas Tull ’s US Innovative Technology Fund.
CIO
SEPTEMBER 18, 2023
When the timing was right, Chavarin honed her skills to do training and coaching work and eventually got her first taste of technology as a member of Synchrony’s intelligent virtual assistant (IVA) team, writing human responses to the text-based questions posed to chatbots.
TechCrunch
NOVEMBER 17, 2020
billion investment plan, which includes its first cloud data center in the country. NTT data is investing in Calabria. We mainly invest in SaaS companies with some proven traction in the market – but overall, we seek the best technology entrepreneurs that want to make an impact. Material science and biotech.
Crunchbase News
APRIL 8, 2024
Table of contents Late stage and technology growth Early stage Seed stage Exits IPOs M&A The big picture Methodology Glossary of funding terms Late stage and technology growth We’ll start with late-stage dealmaking, which still attracts more money than any other stage, even at the current, somewhat depressed levels.
Expert insights. Personalized for you.
110 
Let's personalize your content